MRJ Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $3.16M | Sell |
53,575
-3,625
| -6% | -$180K | 1.83% | 23 |
|
|
2021
Q3 | $2.46M | Sell |
57,200
-1,753
| -3% | -$77.7K | 1.44% | 33 |
|
|
2021
Q2 | $2.31M | Sell |
58,953
-200
| -0.3% | -$7.78K | 1.34% | 35 |
|
|
2021
Q1 | $2.14M | Sell |
59,153
-900
| -1% | -$32K | 1.34% | 34 |
|
|
2020
Q4 | $2.21M | Sell |
60,053
-3,243
| -5% | -$119K | 1.49% | 30 |
|
|
2020
Q3 | $2.2M | Hold |
63,296
| – | – | 1.7% | 24 |
|
|
2020
Q2 | $1.96M | Buy |
63,296
+14,335
| +29% | +$487K | 1.67% | 25 |
|
|
2020
Q1 | $1.52M | Sell |
48,961
-35,099
| -42% | -$1.2M | 1.63% | 26 |
|
|
2019
Q4 | $3.12M | Hold |
84,060
| – | – | 1.75% | 27 |
|
|
2019
Q3 | $2.87M | Hold |
84,060
| – | – | 1.67% | 29 |
|
|
2019
Q2 | $3.45M | Sell |
84,060
-737
| -0.9% | -$29.3K | 2% | 23 |
|
|
2019
Q1 | $3.42M | Hold |
84,797
| – | – | 2.05% | 22 |
|
|
2018
Q4 | $3.51M | Sell |
84,797
-4,006
| -5% | -$166K | 2.4% | 21 |
|
|
2018
Q3 | $3.71M | Sell |
88,803
-1,054
| -1% | -$40.6K | 2.03% | 25 |
|
|
2018
Q2 | $3.09M | Buy |
89,857
+372
| +0.4% | +$12.7K | 1.71% | 32 |
|
|
2018
Q1 | $3.01M | Hold |
89,485
| – | – | 1.65% | 33 |
|
|
2017
Q4 | $3.08M | Hold |
89,485
| – | – | 1.65% | 33 |
|
|
2017
Q3 | $3.03M | Hold |
89,485
| – | – | 1.7% | 35 |
|
|
2017
Q2 | $2.85M | Hold |
89,485
| – | – | 1.69% | 32 |
|
|
2017
Q1 | $2.9M | Hold |
89,485
| – | – | 1.74% | 30 |
|
|
2016
Q4 | $2.76M | Hold |
89,485
| – | – | 1.76% | 29 |
|
|
2016
Q3 | $2.88M | Hold |
89,485
| – | – | 1.89% | 28 |
|
|
2016
Q2 | $2.99M | Sell |
89,485
-1,791
| -2% | -$57.2K | 2.04% | 24 |
|
|
2016
Q1 | $2.57M | Buy |
91,276
+8,853
| +11% | +$253K | 1.75% | 30 |
|
|
2015
Q4 | $2.52M | Sell |
82,423
-2,319
| -3% | -$73K | 1.65% | 30 |
|
|
2015
Q3 | $2.52M | Buy |
84,742
+1,054
| +1% | +$33.8K | 1.6% | 33 |
|
|
2015
Q2 | $2.66M | Hold |
83,688
| – | – | 1.48% | 32 |
|
|
2015
Q1 | $2.76M | Hold |
83,688
| – | – | 1.55% | 32 |
|
|
2014
Q4 | $2.47M | Buy |
83,688
+8,432
| +11% | +$242K | 1.37% | 34 |
|
|
2014
Q3 | $2.11M | Hold |
75,256
| – | – | 1.22% | 37 |
|
|
2014
Q2 | $2.12M | Buy |
75,256
+19,499
| +35% | +$556K | 1.22% | 37 |
|
|
2014
Q1 | $1.7M | Hold |
55,757
| – | – | 1.03% | 41 |
|
|
2013
Q4 | $1.62M | Hold |
55,757
| – | – | 1.02% | 40 |
|
|
2013
Q3 | $1.52M | Sell |
55,757
-527
| -0.9% | -$14.3K | 1.06% | 37 |
|
|
2013
Q2 | $1.5M | Buy |
+56,284
| New | +$1.56M | 1.07% | 38 |
|
Other funds holding PFE
MRJ Capital's PFE Position: Q4 2021 in Review
MRJ Capital reduced its Pfizer (PFE) stake by 6.3% in Q4 2021, selling an estimated $180K and leaving 53,575 shares worth $3.16M. The position accounts for 1.83% of the portfolio, ranked #23.
MRJ Capital first reported a position in PFE in Q2 2013 and has held it in 35 quarters since. The position peaked at $3.71M in Q3 2018. 3,262 funds tracked by Wall St. Rank hold PFE as of Q4 2021.
- MRJ Capital held 53,575 shares of Pfizer worth $3.16M as of Q4 2021.
- MRJ Capital sold 3,625 Pfizer shares in Q4 2021, an estimated $180K.
- Pfizer made up 1.83% of MRJ Capital's portfolio in Q4 2021, its #23 holding.
- MRJ Capital first reported a position in Pfizer in Q2 2013 and has held it in 35 quarters since.
- MRJ Capital's Pfizer position peaked at $3.71M in Q3 2018.
- 3,262 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.
Based on MRJ Capital's 13F filing for Q4 2021, filed 25 Jan 2022.